Michel Nakache also promoted by McCann Health to Head of Global Clients Unit

Shares of Chipotle Mexican Grill Inc fell almost 6 percent in morning trading on Wednesday, a day after the popular burrito chain operator said it would temporarily shut a Massachusetts restaurant after four employees fell sick. Chipotle is trying to repair its reputation after a series of food-safety incidents, including two E. coli outbreaks that […]

Roche receives approval in China for the CINtec PLUS Cytology test …

U.S. drugmaker Bristol-Myers Squibb said on Tuesday it had stopped “certain initiatives” in China …

Sanofi SA and Merck & Co. Inc. announced that they are ending a 22-year-old joint venture to sell vaccines in Europe …

March 8, 2016 By Alex Keown, BioSpace.com Breaking News Staff   FOSTER CITY, Calif. – Gilead Sciences (GILD) could owe Merck (MRK) more than $3 billion in a patent dispute over its block buster hepatitis C treatment if a jury finds Merck’s own hepatitis C patents are still viable, Bloomberg reported this morning. Merck challenged […]

India has given private assurances that it will not grant licences allowing local firms to override patents and make cheap copies of drugs by big Western drugmakers, a U.S. business advocacy group said.   The comments were revealed in a submission last month by the U.S.-India Business Council (USIBC) to the U.S. Trade Representative (USTR), […]

People with anxiety may not be able to distinguish between neutral and threatening stimuli as well as individuals without anxiety, a small study suggests. Researchers designed a sound experiment to explore the brain’s plasticity, or its ability to change and respond to new situations. These changes influence how the brain reacts to stimuli and whether […]

For adolescents, low cardiorespiratory fitness and poor muscle strength increase their risk for type 2 diabetes later in life, regardless of body weight, according to a study of young men in Sweden. “Not only were both low aerobic and muscular fitness linked with a higher long-term risk of diabetes, but this was true even among […]

Celldex Therapeutics Inc said it would discontinue a late-stage study of its brain cancer vaccine after an independent interim analysis suggested the therapy might not show a statistically significant benefit in patient survival compared with standard chemotherapy. Celldex shares more than halved to $3.76 in premarket trading on Monday. The vaccine, Rintega, belongs to an […]